Stryker, a global leader in medical technology, finalized the acquisition of MOLLI Surgical Inc., a privately held Sunnybrook Research Institute spin-off in California. MOLLI Surgical specializes in wireless, soft-tissue localization solutions designed for breast-conserving surgeries. Its flagship MOLLI 2 product—comprising a tiny 3.2?mm marker and a tablet offering multi-modal (distance, visual, auditory, and 3D) guidance—enhances surgical precision and workflow efficiency, complementing Stryker’s existing breast oncology technologies